157 related articles for article (PubMed ID: 18240004)
1. Association of urokinase gene 3'-UTR T/C polymorphism with calcium oxalate urolithiasis in children.
Ozturk M; Kordan Y; Cangul H; Dogan HS; Kilicarslan H; Vuruskan H; Oktay B
Int Urol Nephrol; 2008; 40(3):563-8. PubMed ID: 18240004
[TBL] [Abstract][Full Text] [Related]
2. Association of urokinase gene 3'-UTR polymorphism with calcium oxalate nephrolithiasis.
Mittal RD; Bid HK; Kumar A; Bhandari M
J Endourol; 2006 Feb; 20(2):157-60. PubMed ID: 16509805
[TBL] [Abstract][Full Text] [Related]
3. Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis.
Tsai FJ; Lin CC; Lu HF; Chen HY; Chen WC
Urology; 2002 Mar; 59(3):458-61. PubMed ID: 11880102
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease.
Chen WC; Chen HY; Wu HC; Wu MC; Hsu CD; Tsai FJ
Urol Res; 2003 Jul; 31(3):218-22. PubMed ID: 12719950
[TBL] [Abstract][Full Text] [Related]
5. Association of calcium urolithiasis with urokinase P141L and 3'-UTR C>T polymorphisms in a Japanese population.
Hagikura S; Wakai K; Kawai S; Goto Y; Naito M; Hagikura M; Gotoh M; Hamajima N
Urolithiasis; 2013 Feb; 41(1):47-52. PubMed ID: 23532423
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones.
Chen WC; Wu HC; Chen HY; Wu MC; Hsu CD; Tsai FJ
Urol Res; 2001 Oct; 29(5):321-4. PubMed ID: 11762793
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin receptor gene polymorphism: a possible genetic marker for patients with calcium oxalate stones.
Chen WC; Wu HC; Lu HF; Chen HY; Tsai FJ
Eur Urol; 2001 Jun; 39(6):716-9. PubMed ID: 11464063
[TBL] [Abstract][Full Text] [Related]
8. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
[TBL] [Abstract][Full Text] [Related]
9. No association of vitamin D receptor gene BsmI polymorphisms with calcium oxalate stone formation.
Chen WC; Chen HY; Hsu CD; Wu JY; Tsai FJ
Mol Urol; 2001; 5(1):7-10. PubMed ID: 11689145
[TBL] [Abstract][Full Text] [Related]
10. Association of E-cadherin gene 3'-UTR C/T polymorphism with calcium oxalate stone disease.
Tsai FJ; Wu HC; Chen HY; Lu HF; Hsu CD; Chen WC
Urol Int; 2003; 70(4):278-81. PubMed ID: 12740491
[TBL] [Abstract][Full Text] [Related]
11. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
12. Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease.
Chen WC; Chen HY; Lu HF; Hsu CD; Tsai FJ
BJU Int; 2001 Feb; 87(3):168-71. PubMed ID: 11167636
[TBL] [Abstract][Full Text] [Related]
13. Osteocalcin gene Hind III polymorphism is not correlated with calcium oxalate stone disease.
Chen WC; Chen HY; Wu JY; Chen YT; Tsai FJ
Urol Res; 2001 Apr; 29(2):98-101. PubMed ID: 11396736
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the development of calcium oxalate stones and polymorphisms in the fibronectin gene in the Uighur population of the Xinjiang region of China.
Murat M; Aekeper A; Yuan LY; Alim T; Du GJ; Abdusamat A; Wu GW; Aniwer Y
Genet Mol Res; 2015 Oct; 14(4):13728-34. PubMed ID: 26535688
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characteristics of the elderly with recurrent calcium oxalate stones.
Yagisawa T; Hayashi T; Yoshida A; Okuda H; Kobayashi H; Ishikawa N; Goya N; Toma H
BJU Int; 1999 Jun; 83(9):924-8. PubMed ID: 10368230
[TBL] [Abstract][Full Text] [Related]
16. Association of Urokinase Gene 3'-UTR T/C polymorphism with bladder cancer.
Manchanda PK; Bid HK; Mittal RD
Urol Int; 2006; 77(1):81-4. PubMed ID: 16825821
[TBL] [Abstract][Full Text] [Related]
17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
18. Klotho gene polymorphism of rs3752472 is associated with the risk of urinary calculi in the population of Han nationality in Eastern China.
Xu C; Song RJ; Yang J; Jiang B; Wang XL; Wu W; Zhang W
Gene; 2013 Sep; 526(2):494-7. PubMed ID: 23756195
[TBL] [Abstract][Full Text] [Related]
19. TAP 2 gene Msp-I polymorphism might be associated with calcium oxalate stone disease.
Huang SH; Chen RH; Wan L; Tsai FJ; Chen WC
Urol Int; 2005; 75(3):264-8. PubMed ID: 16215317
[TBL] [Abstract][Full Text] [Related]
20. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
